Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Sarcoma 2 Esophageal Neoplasms 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Thoracic Diseases 1 Skin Neoplasms 1 Prolactinoma 1 Pituitary ACTH Hypersecretion 1 Paraproteinemias 1 Pancreatic Ductal Adenocarcinoma 1 Nervous System Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Monoclonal Gammopathy of Undetermined Significance 1 Lung Neoplasms 1 Leiomyosarcoma 1 Immunoglobulin Light-chain Amyloidosis 1 Gigantism 1 Endometrial Neoplasms 1 Congenital Abnormalities 1 Combined Pituitary Hormone Deficiency 1 Colorectal Neoplasms 1 Clear-cell metastatic renal cell carcinoma 1 Central Nervous System Neoplasms 1 Central Nervous System Diseases 1 Carcinosarcoma 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1

Interventions

Specimen Handling 4 Gemcitabine 3 Doxorubicin 3 liposomal doxorubicin 2 Trabectedin 2 Magnetic Resonance Spectroscopy 2 Dacarbazine 2 Biopsy 2 toripalimab 1 regorafenib 1 peposertib 1 cemiplimab 1 anlotinib 1 abemaciclib 1 X-Rays 1 Tretinoin 1 Tissue Banks 1 Tablets 1 Surgical Procedures, Operative 1 Standard of Care 1 Rosuvastatin Calcium 1 Radiotherapy 1 Quality of Life 1 Nivolumab 1 Neoadjuvant Therapy 1 Midazolam 1 Injections 1 Immunoglobulin G 1 Ifosfamide 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Leiomyosarcoma × Tissue Banks × Clear all

NCT04925089 2026-02-17

Localized Leiomyosarcoma Biomarker Protocol

University of Michigan Rogel Cancer Center

Leiomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡